Skip to main content
. Author manuscript; available in PMC: 2017 Oct 28.
Published in final edited form as: J Control Release. 2016 Jun 9;240:504–526. doi: 10.1016/j.jconrel.2016.06.016

Figure 11.

Figure 11

Efficacy of orally delivered 100 mg/kg or 300 mg/kg redox nanoparticles (RNPo) and 35 mg/kg mesalamine (5-ASA) in a murine DSS-induced colitis model. Efficacy evaluated by measuring (A) disease activity index, (B) colon length, and (C) secretion of inflammatory cytokine IL-1β. Orally delivered RNPo at the dose of 300 mg/kg showed better efficacy than mesalamine at 35 mg/kg (p < 0.05). Adapted from reference [200] with permission.